FDA approves monthly subcutaneous amivantamab plus lazertinib for EGFR-mutated advanced NSCLC, cutting clinic time and ...
The FDA has issued a complete response letter to AstraZeneca regarding its application for subcutaneous administration of Saphnelo (anifrolumab) in adults with systemic lupus erythematosus. The ...
It remains unknown whether or not short-term androgen deprivation (STAD) improves survival among men with intermediate-risk prostate cancer (IRPC) treated with dose-escalated radiotherapy (RT).
AstraZeneca has hit what appears to be a minor speed bump in gaining clearance in the U.S. for its subcutaneous (SC) version of lupus treatment Saphnelo. The FDA has sent the British drugmaker a ...
The US Food and Drug Administration (FDA) issued a complete response letter (CRL) regarding the Biologics License Application (BLA) for Saphnelo (anifrolumab) for subcutaneous administration in adult ...
Update on US regulatory review of Saphnelo subcutaneous administration in systemic lupus erythematosus A decision from the FDA on the updated application for Saphnelo SC is expected in the first half ...
Viking Therapeutics, Inc. faces significant challenges with VK2735, lacking differentiation from established obesity treatments like ZEPBOUND and WEGOVY. Phase 2 data highlight tolerability issues at ...
Update on US regulatory review of Saphnelo subcutaneous administration in systemic lupus erythematosus The US Food and Drug Administration (FDA) issued a complete response letter (CRL) regarding the ...
The MarketWatch News Department was not involved in the creation of this content. GAITHERSBURG, Md. and CAMBRIDGE, United Kingdom, Feb. 04, 2026 (GLOBE NEWSWIRE) -- Revolo Biotherapeutics Limited ...
Title: IRL201104, A Novel Immunomodulatory Peptide, shows efficacy through the sublingual and subcutaneous routes in an allergen driven model of Atopic Dermatitis Presenter: Dr. Jorge De Alba, Vice ...
GAITHERSBURG, Md. and CAMBRIDGE, United Kingdom, Feb. 04, 2026 (GLOBE NEWSWIRE) -- Revolo Biotherapeutics Limited ("Revolo”) today announced that it will present a poster on its lead candidate, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results